Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice

A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology.

dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.

Exploring innovative solutions to improve the healthcare of the aging and diseased population continues to be a global challenge. Among a number of strategies toward this goal, tissue engineering and regenerative medicine (TERM) has gradually evolved into a promising approach to meet future needs of patients. TERM has recently received increasing attention in Asia, as evidenced by the markedly increased number of researchers, publications, clinical trials, and translational products. This review aims to give a brief overview of TERM development in Asia over the last decade by highlighting some of the important advances in this field and featuring major achievements of representative research groups. The development of novel biomaterials and enabling technologies, identification of new cell sources, and applications of TERM in various tissues are briefly introduced. Finally, the achievement of TERM in Asia, including important publications, representative discoveries, clinical trials, and examples of commercial products will be introduced. Discussion on current limitations and future directions in this hot topic will also be provided.

Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia.

Enhancer Histone Acetylation Modulates Transcriptional Bursting Dynamics of Neuronal Activity-Inducible Genes.

Despite rapid progresses in the genome-editing field, in vivo simultaneous overexpression of multiple genes remains challenging. We generated a transgenic mouse using an improved dCas9 system that enables simultaneous and precise in vivo transcriptional activation of multiple genes and long noncoding RNAs in the nervous system. As proof of concept, we were able to use targeted activation of endogenous neurogenic genes in these transgenic mice to directly and efficiently convert astrocytes into functional neurons in vivo. This system provides a flexible and rapid screening platform for studying complex gene networks and gain-of-function phenotypes in the mammalian brain.

In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice

Mature fruit abscission (MFA) is an important trait in terms of both harvest and yield. MFA can affect the production and economic value of melon fruit. An F3 population segregating for a single gene and derived from a cross between line M2-10, which shows no mature fruit abscission (None MFA), and the MFA line ZT00091 was used to map candidate genes. Specific length amplified fragment (SLAF) sequencing, in conjunction with bulked-segregant analysis (BSA), was used to map loci governing the natural fruit abscission of plants composing the F3-57 family. A candidate locus, mfa10.1, located on chromosome 10 between genomic positions 73,229 and 818,251, was obtained. An insertion-deletion (InDel) marker and 46 recombinant individuals were used to narrow the candidate region to within 35 kb at the genomic position of 650,203 to 685,250; this region included six candidate genes. qRT–PCR gene expression and gene sequence data showed that the CmARM14 gene, which encodes a RING-type E3 ubiquitin transferase (MELO3C012406), was a candidate for melon MFA. Subcellular localization observations revealed that the CmARM14 fusion protein was localized to the golgi apparatus. Taken together, these results provide a molecular basis for melon breeding.

/pdf/primary-mapping-and-analysis-of-the-cmarm14-candidate-gene-le5qicj2.pdf

Junming Zhang

Papers

In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice

Primary Mapping and Analysis of the CmARM14 Candidate Gene for Mature Fruit Abscission in Melon